The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.

The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.

The cross talk between RAGE and angiotensin II (AngII) activation may be important in the development of atherosclerosis. Soluble RAGE (sRAGE), a truncated soluble form of the receptor, acts as a decoy and prevents the inflammatory response mediated by RAGE activation. In this study, we sought to de...

Full description

Bibliographic Details
Main Authors:	Dajeong Lee, Kyung Hye Lee, Hyelim Park, Soo Hyuk Kim, Taewon Jin, Soyoung Cho, Ji Hyung Chung, Soyeon Lim, Sungha Park
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3731311?pdf=render

Similar Items

Retraction. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Published: (2014-01-01)

Radiological assessment of effectiveness of soluble RAGE in attenuating Angiotensin II-induced LVH mouse model using in vivo 9.4T MRI
by: Dan Heo, et al.
Published: (2019-06-01)

Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis.
by: Gwon-Soo Jung, et al.
Published: (2014-01-01)

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases
by: Eun Ji Lee, et al.
Published: (2013-12-01)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
by: Bin Fang, et al.
Published: (2018-10-01)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Karen Alejandra Méndez-Lara, et al.
Published: (2020-11-01)

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
by: Polyxeni T Mantani, et al.
Published: (2015-01-01)

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
by: Li Jing, et al.
Published: (2011-12-01)

Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice
by: Wen-Jun Wang, et al.
Published: (2006-11-01)

Chung Hun Wha Dam Tang attenuates atherosclerosis in apolipoprotein E-deficient mice via the NF-κB pathway
by: Yeonsoo Joe, et al.
Published: (2019-12-01)

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice
by: Juying Han, et al.
Published: (2018-04-01)

Cholesterol-lowering pattern affects the progression of atherosclerosis in apolipoprotein E deficient mice
by: Yusuke Masuda, et al.
Published: (2016-12-01)

Effects of high density lipoproteins on the progression of atherosclerosis in apolipoprotein E-deficient mice
by: Choudhury, Robin P.
Published: (2002)

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction
by: Hua Sun, et al.
Published: (2018-02-01)

Adiponectin receptor 2 deficiency results in reduced atherosclerosis in the brachiocephalic artery in apolipoprotein E deficient mice.
by: Anna Lindgren, et al.
Published: (2013-01-01)

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
by: Morcos Michael, et al.
Published: (2007-03-01)

<i>Nelumbo nucifera</i> Receptaculum Extract Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
by: Soyoung Cho, et al.
Published: (2019-04-01)

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
by: Fei Zheng, et al.
Published: (2014-01-01)

Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice.
by: Jun Liu, et al.
Published: (2014-01-01)

Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
by: Weibin Shi, et al.
Published: (2004-11-01)

Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis
by: Cong-Lin Liu, et al.
Published: (2017-04-01)

Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis.
by: Seul-Gee Lee, et al.
Published: (2019-01-01)

Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice
by: Yan-Yong Xu, et al.
Published: (2015-10-01)

Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice
by: Jiawei Liao, et al.
Published: (2020-10-01)

Mouse RAGE Variant 4 Is a Dominant Membrane Receptor that Does Not Shed to Generate Soluble RAGE.
by: Yunqian Peng, et al.
Published: (2016-01-01)

RAGE ligands stimulate angiotensin II type I receptor (AT1) via RAGE/AT1 complex on the cell membrane
by: Serina Yokoyama, et al.
Published: (2021-03-01)

The Effect of ERK Signaling Pathway on the Level of Soluble RAGE (sRAGE) Peptide in AGE-Induced Oxidative Stress
by: Farnosh Shemirani, et al.
Published: (2017-05-01)

Activation of CREB Protein With Tabersonine Attenuates STAT3 During Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Sen Shi, et al.
Published: (2020-03-01)

RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice.
by: Wen-ping Zhou, et al.
Published: (2015-01-01)

The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21
by: Xiaona Xu, et al.
Published: (2019-01-01)

Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E–deficient mice
by: Jiqu Xu, et al.
Published: (2018-07-01)

Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E–deficient mice
by: Xiaokun Guo, et al.
Published: (2019-01-01)

Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice
by: Jiqu Xu, et al.
Published: (2018-01-01)

RAGE receptor and its soluble isoforms in diabetes mellitus complications
by: Mauren Isfer Anghebem Oliveira, et al.
Published: (2013-04-01)

Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage
by: Bartosz Sokół, et al.
Published: (2017-01-01)

The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE.
by: Stefania Di Maggio, et al.
Published: (2016-01-01)

Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
by: A C Liu, et al.
Published: (1994-12-01)

Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies
by: Han Liu, et al.
Published: (2019-01-01)

Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice
by: A.L.N. Gadioli, et al.
Published: (2009-12-01)

Apolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
by: Jeong Shim, MD, et al.
Published: (2017-10-01)